Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
Findell Capital Management LLC Releases Comprehensive Research Coverage Report on ESTA : Nasdaq
Jefferies Maintains Establishment Labs(ESTA.US) With Buy Rating, Cuts Target Price to $65
Jefferies analyst Matthew Taylor maintains $Establishment Labs(ESTA.US)$ with a buy rating, and adjusts the target price from $80 to $65.According to TipRanks data, the analyst has a success rate of 6
Establishment Labs Is Maintained at Buy by Mizuho
Establishment Labs Is Maintained at Buy by Mizuho
Express News | Mizuho Bank: Maintains a buy rating for Establishment Labs Holdings (ESTA.US), with the target price adjusted from $65.00 to $70.00.
Mizuho Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $70
Mizuho analyst Anthony Petrone maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from $65 to $70.
Mizuho Securities Maintains Establishment Labs(ESTA.US) With Buy Rating, Raises Target Price to $70
Mizuho Securities analyst Anthony Petrone maintains $Establishment Labs(ESTA.US)$ with a buy rating, and adjusts the target price from $65 to $70.According to TipRanks data, the analyst has a success
Express News | TD Cowen Inc 7.75% senior notes due 15/06/33 USD25 raised the target price of Establishment Labs Holdings Inc from USD 60 to USD 75.
Express News | Establishment Labs Holdings Inc : TD Cowen Raises Target Price to $75 From $60
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Raises Target Price to $75
TD Cowen analyst Josh Jennings maintains $Establishment Labs(ESTA.US)$ with a buy rating, and adjusts the target price from $60 to $75.According to TipRanks data, the analyst has a success rate of 52.
Swelling Losses Haven't Held Back Gains for Establishment Labs Holdings (NASDAQ:ESTA) Shareholders Since They're up 124% Over 5 Years
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you can make far more than 100% on a really good stock. For instance, the price of
BTIG Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $62
BTIG analyst Marie Thibault maintains $Establishment Labs(ESTA.US)$ with a buy rating, and maintains the target price at $62.According to TipRanks data, the analyst has a success rate of 33.6% and a t
Express News | Establishment Labs Holdings: CDRH has sent a letter to the company stating that PMA approval is contingent on the company's manufacturing facilities being inspected by the FDA.
Express News | The FDA's Center for Devices and Radiological Health has completed the review of Establishment Labs Holdings' application for the marketing approval of Motiva implants.
Express News | Establishment Labs Holdings: Cdrh Issued Letter to Co That Pma Is Approvable Subject to Acceptable FDA Inspection of Co's Manufacturing Facilities
Express News | Establishment Labs Holdings-Center for Devices & Radiological Health of FDA Finished Review of Co's Premarket Approval Application for Motiva Implants
Analysts Expect Breakeven For Establishment Labs Holdings Inc. (NASDAQ:ESTA) Before Long
Citi Downgrades Establishment Labs(ESTA.US) to Hold Rating, Maintains Target Price $60
Citi analyst Joanne Wuensch downgrades $Establishment Labs(ESTA.US)$ to a hold rating, and maintains the target price at $60.According to TipRanks data, the analyst has a success rate of 62.2% and a t
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
NEW YORK--(BUSINESS WIRE)-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics a
Citi Upgrades Edwards, Tandem; Cuts Nevro, Establishment Labs